Akanda Filing Offers 10,000 Preferred Shares With Stated Gross Proceeds of $10 Million
Key Facts
Akanda’s latest disclosure does not establish a new offering of 4,823,151 ordinary shares on November 17; that figure appeared in an F-1 registration dated October 1, 2026. The F-1/A amendment filed on November 6 instead offers 10,000 convertible Series A preferred shares, with stated gross proceeds of $10 million. The amendment also registers up to 11,312,217 ordinary shares that may be issued upon conversion, based on an assumed conversion price of $0.884 per share. That means the latest offering figures relate to a convertible financing instrument, not the ordinary-share offering in the earlier registration. In its disclosure, the company detailed the instrument’s terms and uses for part of the proceeds, without specifying the destination of most of the net proceeds.
The October registration offered up to 4,823,151 ordinary shares at an assumed offering price of $3.11 per share, with expected gross proceeds of $15 million. The company said at the time that the assumed price equaled the last reported share price on the Nasdaq Capital Market on September 23, 2026. That structure differs from the November amendment, which includes preferred shares with a stated value of $1,000 per share, along with ordinary shares issuable upon conversion. The latest prospectus registered a maximum of 11,312,217 ordinary shares based on an assumed conversion price of $0.884. Accordingly, the figure of 4,823,151 should not be treated as the size of the offering in the latest amendment or as a new announcement on November 17.
Akanda had not allocated most of the offering’s net proceeds to a specific use as of the prospectus, but it identified certain items. The company said it expects to spend up to $3 million on marketing and informational awareness campaigns conducted by third parties. It also earmarked about $575,000 to repay certain indebtedness. The disclosure does not present these amounts as a complete plan for allocating net proceeds, leaving the use of most of them unspecified. The filing therefore does not support saying that the financing is generally intended for operations or to repay existing debt, apart from the specific debt item identified in the prospectus.
Series A shares carry mandatory monthly dividends at an annual rate of 10% of their stated value, beginning to accrue on January 1, 2027. The prospectus says the dividends may be paid in cash or ordinary shares. This term links the cost of financing to when the dividends begin and how they are settled, while making the issuance of ordinary shares a possible means of payment. The number of shares that may be issued upon conversion depends on the conversion price, according to the company’s disclosure. The number of shares registered based on the assumed price therefore does not represent a fixed cap for every conversion scenario.
The prospectus illustrates the effect of a change in the conversion price using an assumed floor price of $0.208 per share. At that level, the number of ordinary shares resulting from conversion could reach 48,076,923, according to the company. That compares with the registered limit of 11,312,217 shares based on the assumed conversion price of $0.884. The figures show that the potential share count changes with the conversion price, while the prospectus does not provide a final number of shares to be issued. Actual share issuance remains tied to the conversion terms and the applicable price.
The financing terms come as the company has announced a change in its operational direction. On September 24, 2026, the board decided to stop pursuing cannabis cultivation or any future business related to it and to focus on growing and managing its subsidiary First Towers, with the possibility of pursuing other businesses. In its first-half 2026 results, Akanda reported revenue of $404,394, compared with zero in the same period of 2025, and said the revenue came from First Towers’ operations in Mexico. The group posted a net loss of $6,246,310 in the six months ended June 30, 2026, compared with $815,001 in the corresponding period of 2025. The company attributed the widening loss mainly to higher operating results.
Akanda said it had about $755,238 in cash and cash equivalents on June 30, 2026. The company estimated that this amount, together with expected future revenue and excluding any future capital financing, would fund operations at the current spending rate for about five months. That estimate reflects liquidity at the end of June and is not an update of cash available on November 17. In its November disclosure, Nasdaq said it had given the company until December 13, 2026, to regain compliance with the minimum stockholders’ equity requirement. The company added that it may seek a further extension if necessary, without the disclosure asserting that the announced financing will achieve compliance.
In trading, AKAN closed at $2.21 on November 16, 2026, according to EL7 data. The latest disclosure did not include a documented high and low price range for that session. The closing price is also from the day before the story date and does not establish a market response to the registration amendment dated November 6. The next stated deadline in the disclosure remains December 13, 2026, the final date under the extension granted to demonstrate compliance with the stockholders’ equity requirement. The company said it may seek a further extension if needed.